Fig. 3.

Proportion of LC-treated patients achieving age-specific KDOQI serum phosphorus target levels by treatment week. Age-specific KDOQI serum phosphorus target levels were defined as: ≤1.78 mmol/dL for adolescents ≥12 years to < 18 years old and ≤ 1.94 mmol/dL for children ≥10 years to < 12 years old. Data are presented for patients from per-protocol set 2, which included all patients who received LC for at least 8 weeks during part 2 and/or part 3, and who had serum phosphorus data available for analysis, and calculated based on the number of patients with serum phosphorus data available for each time point

LC lanthanum carbonate, KDOQI Kidney Disease Outcomes Quality Initiative